Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2351)
  2. Meeting Abstract (1873)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (101)
  6. Guidelines (40)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (23)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4752)
  2. Department of Medicine (4750)
  3. Center for Pancreatic Cancer Research (2317)
  4. Surgery (1067)
  5. Survivorship Research (1014)
  6. Epidemiology and Biostatistics (844)

More Groups

People
  1. Eileen O'Reilly (805)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (227)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (148)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (322)
  5. American Association for Cancer Research (282)
  6. Wiley Blackwell (243)

More Publishers

Results (4752)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase II trial of intravenous R05137382/GC33 at 1600 mg every other week and placebo in previously treated patients with unresectable advanced hepatocellular carcinoma (HCC; NCT01507168)
    Meeting Abstract

    Yen, C. J.; Daniele, B.; Kudo, M.; Merle, P.; Park, J. W.; Ross, P. J.; Peron, J. M.; Ebert, O.; Chan, S. L.; Tung, R.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Can induction chemotherapy improve dysphagia in locally advanced esophageal/GEJ cancer?
    Meeting Abstract

    Won, E.; Ilson, D. H.; Herrera, J.; Janjigian, Y. Y.; Ku, G. Y.; Rizk, N. P.; Sarkaria, I. S.; Rusch, V. W.; Adusumilli, P. S.; Bains, M. S.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Activity of genacitabine/5-FU combination in refractory esophagogastrie (EG) cancer
    Meeting Abstract

    Won, E.; Ilson, D. H.; Chou, J. F.; Capanu, M.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • APACT: A phase 3 randomized, open-label, multicenter trial evaluating the use of adjuvant nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients (pts) with surgically resected ductal pancreatic adenocarcinoma (PDA)
    Meeting Abstract

    Tempero, M. A.; Cardin, D. B.; Biankin, A.; Goldstein, D.; Moore, M.; O'Reilly, E. M.; Philip, P. A.; Riess, H.; Macarulla, T.; Yung, L.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Sznol, M.; Kluger, H. M.; Callahan, M. K.; Postow, M. A.; Gordon, R. A.; Segal, N. H.; Rizvi, N. A.; Lesokhin, A. M.; Atkins, M. B.; Kirkwood, J. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Early predictors of prolonged overall survival (OS) in patients (pts) on first-line chemotherapy (CT) for metastatic colorectal cancer (mCRC): An ARCAD study with individual patient data (IPD) on 10,962 pts
    Meeting Abstract

    Sommeijer, D. W.; Shi, Q.; Saad, E. D.; Coart, E.; Buyse, M. E.; Burzykowski, T.; Meyers, J. P.; Maughan, T.; Adams, R. A.; Seymour, M. T.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Preliminary data from a multi-arm expansion study of MEDI4736, an anti-PD-L1 antibody
    Meeting Abstract

    Segal, N. H.; Antonia, S. J.; Brahmer, J. R.; Maio, M.; Blake-Haskins, A.; Li, X.; Vasselli, J.; Ibrahim, R. A.; Lutzky, J.; Khieif, S.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase 1 study of PF-05082566 (anti-4-1BB) in patients with advanced cancer
    Meeting Abstract

    Segal, N. H.; Gopal, A. K.; Bhatia, S.; Kohrt, H. E.; Levy, R.; Pishvalan, M. J.; Houot, R.; Bartlett, N.; Nghlem, P.; Kronenberg, S. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase I dose escalation and cohort expansion study of lirilumab (anti-KIR; BMS-986015) in combination with nivolumab (anti-PD-1; BMS-936558, ONO-4538) in advanced solid tumors
    Meeting Abstract

    Segal, N. H.; Hodi, F. S.; Sanborn, R. E.; Gajewski, T.; Wolchok, J. D.; Urba, W. J.; Fox, B. A.; Topallan, S. L.; Pardoll, D. M.; Kollia, G.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Gemcitabine-related pnemonitis: Elucidation of risk factors
    Meeting Abstract

    Sahin, I. H.; Geyer, A.; Kelly, D.; O'Reilly, E. M.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save